コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sufficiently pure to support high-efficiency nucleic acid amplification.
2 ccurate thermal control and the detection of nucleic acid amplification.
3 pe biosensor compared favorably to those for nucleic acid amplification.
4 body tests were tested again with the use of nucleic acid amplification.
5 ng aptamer labels, hybridization assays, and nucleic acid amplification.
6 chomatis were detected from vaginal swabs by nucleic acid amplification.
7 tion of single-cell genomic DNA using linear nucleic acid amplification.
10 echnologies for milk analysis, in particular nucleic acid amplification and biosensors, is reviewed h
14 y describe recent developments in isothermal nucleic acid amplification and detection, and focus on e
17 x priming amplification, to greatly simplify nucleic acid amplification and real-time quantification
18 other biological assays, such as isothermal nucleic acid amplification and restriction enzyme digest
19 Direct molecular assay (ST Direct) relies on nucleic acid amplification and solid array-based amplico
20 rmined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of
22 or microbial nucleic acid enrichment, random nucleic acid amplification, and automated sequence simil
23 been utilised to develop a novel isothermal nucleic acid amplification assay (SMART) for the detecti
24 icroscopy with the GeneXpert MTB/RIF (Xpert) nucleic acid amplification assay could reduce testing ti
25 utomated assay provides a useful alternative nucleic acid amplification assay for clinical laboratori
26 nty that contamination has occurred during a nucleic acid amplification assay in the absence of a pos
27 latform in which a simple, dry-reagent-based nucleic acid amplification assay is combined with a port
28 We have developed a specific and sensitive nucleic acid amplification assay that is suitable for ro
29 e potential of combining a dry-reagent-based nucleic acid amplification assay with an electrochemical
30 ion window duration was demonstrated using a nucleic acid amplification assay, the Procleix HIV-1/HCV
31 verse transcription PCR (RT-PCR), and TaqMan nucleic acid amplification assays for the rapid detectio
34 assay to results from two currently approved nucleic acid amplification assays in 1,722 female and 1,
37 croBAR is capable of carrying out isothermal nucleic acid amplification assays with real-time fluores
43 ey components necessary to expand the use of nucleic acid amplification-based detection assays toward
45 mic range for the new Xpert MTB/RIF assay, a nucleic acid amplification-based diagnostic system that
50 assembly (CHA) is one of the most promising nucleic acid amplification circuits based on toehold-med
51 he sensitivity, specificity, and rapidity of nucleic acid amplification demonstrate the usefulness of
52 pped with a sample pretreatment device and a nucleic acid amplification device for the rapid diagnosi
53 ave been made in the development of portable nucleic acid amplification devices for near-patient use.
54 ction of viral RNA in both tests is based on nucleic acid amplification followed by hybridization to
59 integrated with real-time DNA/RNA isothermal nucleic acid amplification: Loop-mediated isothermal amp
60 acement amplification (SDA) is an isothermal nucleic acid amplification method based on the primer-di
61 ation (LAMP) of DNA is a powerful isothermal nucleic acid amplification method that can generate upwa
62 est, Staph ID/R, combines a rapid isothermal nucleic acid amplification method, helicase-dependent am
63 (CDC) recommends the performance of a direct nucleic acid amplification method, regardless of smear r
66 Using the DNase-sequence-independent viral nucleic acid amplification method, we identified several
69 aboratory diagnosis, rapid antigen tests and nucleic acid amplification methods may also play a usefu
73 and other NGU pathogens were detected using nucleic acid amplification methods, and DNA sequencing w
78 and Prevention's Mycobacterium tuberculosis nucleic acid amplification (NAA) evaluation program, 27.
79 nder conditions appropriate for evaluating a nucleic acid amplification (NAA) test for Chlamydia trac
80 llent performance of rapid tuberculosis (TB) nucleic acid amplification (NAA) tests and the clear ben
81 t system (BD Affirm VPIII) was compared with nucleic acid amplification (NAA)-based assays for determ
83 equencing DNA microarrays with either random nucleic acid amplification or multiplex PCR for GAS dete
85 c devices of the most popular technology for nucleic acids amplifications, polymerase chain reaction
86 ntial, numerous technical issues, especially nucleic acid amplification, probe specificity, and inter
88 ircuitry can be used to transduce isothermal nucleic acid amplification products into signals that ca
93 field effect transistor methods for sensing nucleic acid amplification rely on establishing the flui
94 nical laboratory include biological culture, nucleic acid amplification, ribosomal protein characteri
95 ing was observed, the failure was due to the nucleic acid amplification step rather than limitations
97 C. difficile assay is an integrated, closed, nucleic acid amplification system that automates sample
98 ert Flu Assay cartridge is a next-generation nucleic acid amplification system that provides multiple
99 ation of DNA (LAMP) is a powerful isothermal nucleic acid amplification technique that can accumulate
100 esults in the negative gray zone by use of a nucleic acid amplification technique, is not suitable fo
101 (MTD) is a rapid diagnostic test based on a nucleic acid amplification technique, which can be used
105 ion of these methods that are independent of nucleic acid amplification techniques and could largely
112 broad range of assays, including isothermal nucleic acid amplification techniques, enzyme-based immu
113 cluding both antigen detection and multiplex nucleic acid amplification techniques, is becoming more
117 o known as hyperbranched RCA) are isothermal nucleic acid amplification technologies that have gained
118 first international standard for HBV DNA for nucleic acid amplification technology (NAT) assays.
119 study period, which was analyzed relative to nucleic acid amplification technology (NAT) yield to est
120 ncy virus type 1 (HIV-1) RNA copy numbers by nucleic acid amplification technology (the NASBA HIV-1 R
121 in the input volume of specimens analyzed by nucleic acid amplification technology can be useful for
122 e compared to those from culture and the LCx nucleic acid amplification test (Abbott Industries, Abbo
123 ratory viral panel (eSensor RVP) multiplexed nucleic acid amplification test (GenMark Diagnostics, In
124 FilmArray Respiratory Panel (RP) multiplexed nucleic acid amplification test (Idaho Technology, Inc.,
125 This work presents an on-chip isothermal nucleic acid amplification test (iNAAT) for the multiple
126 sitive for stx by an alternative FDA-cleared nucleic acid amplification test (NAAT) but were negative
127 2) is a Food and Drug Administration-cleared nucleic acid amplification test (NAAT) for the detection
130 atis or N. gonorrhoeae, two or more positive nucleic acid amplification test (NAAT) results, or a sin
131 seria gonorrhoeae (gonococcus [GC])-positive nucleic acid amplification test (NAAT) results: (i) repe
133 s and symptoms, in contrast with only 3 of 8 nucleic acid amplification test (NAAT)-based studies (P
134 sistant tuberculosis (MDR-TB) screening, all nucleic acid amplification test (NAAT)-positive respirat
136 ave developed an economical, high-throughput nucleic acid amplification test (NAT) for blood-borne vi
137 sts (wet mount, culture, a rapid test, and a nucleic acid amplification test [NAAT]) were performed o
138 ,749 vulvovaginal-swab specimens with both a nucleic acid amplification test and a polymer conjugate-
139 true-negative or false-negative relative to nucleic acid amplification test and/or enzyme immunoassa
140 The Alere i strep A test is an isothermal nucleic acid amplification test designed to offer highly
141 at first vaginal intercourse and a positive nucleic acid amplification test for sexually transmitted
142 ple, sample-to-answer, on-demand, multiplex, nucleic acid amplification test for syndromic diagnosis
143 Qiagen artus C. difficile QS-RGQ kit, a new nucleic acid amplification test for the detection of Clo
144 opment of an internally controlled multiplex nucleic acid amplification test for the detection of den
146 defined as a confirmed positive result on a nucleic acid amplification test or as HIV antibody seroc
148 The Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification test widely used in settings
151 t MTB/RIF (Xpert), a novel, semiautomated TB nucleic-acid amplification test, has renewed interest in
152 of 3 algorithms that detect AHI based on HIV nucleic acid amplification testing (EarlyTest algorithm)
153 Here we report the development of a mobile nucleic acid amplification testing (mobiNAAT) platform u
154 utility of Mycobacterium tuberculosis direct nucleic acid amplification testing (MTD) for pulmonary t
155 rator for improving the harmonization of BKV nucleic acid amplification testing (NAAT) and enabling c
156 tion of Chlamydia trachomatis were tested by nucleic acid amplification testing (NAAT) and in cell cu
157 We evaluated criteria to reduce unnecessary nucleic acid amplification testing (NAAT) for viral path
161 virus infection (AHI); however, the cost of nucleic acid amplification testing (NAAT) makes individu
162 onreactive samples were pooled and tested by nucleic acid amplification testing (NAAT) to identify ac
165 chomatis infection in certain populations by nucleic acid amplification testing (NAAT), as they invol
166 This study presents the verification of nucleic acid amplification testing (NAAT; Gen-Probe Apti
167 ccepted for transplantation.Universal use of nucleic acid amplification testing (NAT) for the screeni
168 igenic organisms (toxigenic culture [TC] and nucleic acid amplification testing [NAAT]) are confounde
170 imens, a useful characteristic in the age of nucleic acid amplification testing for gonococcal infect
171 For all urine specimens, UA, culture, and nucleic acid amplification testing for Neisseria gonorrh
173 f C. trachomatis- or N. gonorrhoeae-specific nucleic acid amplification testing in this metropolitan
174 the introduction of diagnostic M. genitalium nucleic acid amplification testing including antimicrobi
179 Screening of broth enrichment fluids by nucleic acid amplification testing requires careful hand
181 tly, some laboratories have begun adding HIV nucleic acid amplification testing to HIV diagnostic tes
182 est yield on minipool testing, retrospective nucleic acid amplification testing was performed on indi
183 dictive value of the algorithm that included nucleic acid amplification testing were greater than 0.9
185 specimens, known to be gonorrhea positive by nucleic acid amplification testing, provided by females
186 treatment failure determined on the basis of nucleic acid amplification testing, sexual history, and
187 erpretation of gonorrhea tests of cure using nucleic acid amplification testing, this study examined
188 acutely viremic blood donors, identified by nucleic acid amplification testing, were enrolled and mo
192 ymptomatic sexual health screening underwent nucleic acid amplification testing; positive samples and
194 rmed to be positive for HIV-1 and HCV RNA on nucleic acid-amplification testing of "minipools" (pools
197 testing practices since the introduction of nucleic acid amplification tests (NAAT), we surveyed lab
200 lty of culture of this fastidious bacterium, nucleic acid amplification tests (NAATs) are necessary f
203 ning from toxin enzyme immunoassays (EIA) to nucleic acid amplification tests (NAATs) as the primary
206 suggested approaches for confirming positive nucleic acid amplification tests (NAATs) for Chlamydia t
208 is study was to determine the added value of nucleic acid amplification tests (NAATs) for detection o
209 cent sexual assault survivors include use of nucleic acid amplification tests (NAATs) for detection o
211 rapid development of commercially available nucleic acid amplification tests (NAATs) for influenza v
212 r, the true limitation in the realization of nucleic acid amplification tests (NAATs) for near-patien
213 udy evaluated the performance of culture and nucleic acid amplification tests (NAATs) for rectal chla
216 was to define the performance of culture and nucleic acid amplification tests (NAATs) for the diagnos
218 self-obtained vaginal specimens processed by nucleic acid amplification tests (NAATs) has significant
220 ple, recent studies with ribosomal RNA-based nucleic acid amplification tests (NAATs) have demonstrat
223 DTs), digital immunoassays (DIAs), and rapid nucleic acid amplification tests (NAATs) in children and
224 a CT (ACT) (Hologic Inc., San Diego, CA) are nucleic acid amplification tests (NAATs) that detect Chl
225 . Food and Drug Administration (FDA)-cleared nucleic acid amplification tests (NAATs) to culture usin
228 ribing the diagnostic performance of malaria nucleic acid amplification tests (NAATs) using these spe
229 , and illumigene group B Streptococcus (GBS) nucleic acid amplification tests (NAATs) were compared t
231 ests for Chlamydia trachomatis have compared nucleic acid amplification tests (NAATs) with diagnostic
237 ulture-based systems, simplified versions of nucleic acid amplification tests (such as the Xpert MTB/
238 ine whether test performance measures of two nucleic acid amplification tests and a DNA probe were af
239 tive donations were confirmed by alternative nucleic acid amplification tests and IgM and IgG tests,
240 es and gaining in use are techniques such as nucleic acid amplification tests and mass spectroscopy t
242 genitalium coinfections were evaluated using nucleic acid amplification tests and were negative at 1
244 proaches to diagnosis remain inaccurate, and nucleic acid amplification tests are also compromised by
246 ting areas of the clinical spectrum in which nucleic acid amplification tests can make an important c
247 In 10 new studies of asymptomatic patients, nucleic acid amplification tests demonstrated sensitivit
249 gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification tests detects greater numbers
255 between liquid cytologic media and multiple nucleic acid amplification tests for the detection of C.
257 ree commercial identification kits and three nucleic acid amplification tests for the identification
262 dia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification tests is an attractive altern
264 ions and the incremental yield and safety of nucleic acid amplification tests of individual donations
266 retrospectively using enzyme immunoassay and nucleic acid amplification tests on stored specimens.
269 In many clinical microbiology laboratories, nucleic acid amplification tests such as PCR have become
272 y have residual DNA in sputum that confounds nucleic acid amplification tests such as Xpert MTB/RIF.
273 rovide valid specimens for HPV testing using nucleic acid amplification tests, although a few cytolog
274 imens from women are suitable substrates for nucleic acid amplification tests, but enzyme immunoassay
275 strategies, newer testing methods, including nucleic acid amplification tests, have enhanced sensitiv
276 Emerging POC microbiology tests, especially nucleic acid amplification tests, have the potential to
277 n will expand the diagnostic applications of nucleic acid amplification tests, in particular for near
278 that evaluated 1 of 3 commercially available nucleic acid amplification tests, included data from tes
280 With a reference standard of two different nucleic acid amplification tests, the sensitivity and sp
284 le virus RNA with the use of investigational nucleic acid amplification tests; testing was performed
285 lection agencies implemented West Nile virus nucleic acid-amplification tests to identify infected do
286 e respective rates of positive HCV and HIV-1 nucleic acid-amplification tests were 3.3 and 4.1 times
287 horolysis-activated polymerization [PAP]) of nucleic acid amplification that uses 3' blocked primers
288 e quantitative electrochemical monitoring of nucleic acid amplification through PCR is a promising re
290 urists and restaurant staff were examined by nucleic acid amplification using reverse transcription p
291 -activated polymerization (PAP), a method of nucleic acid amplification using serial coupling of pyro
292 and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。